Skip to content

Exercise Program in Women With Pudendal Neuralgia

Comparison of Shear-Wave Elastography of Superficial Pelvic Floor Muscles in Healthy Women and Women With Pudendal Neuralgia

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07446556
Acronym
ELASTIN
Enrollment
83
Registered
2026-03-03
Start date
2026-03-02
Completion date
2026-09-02
Last updated
2026-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pudendal Neuralgia- Physiotherapy

Keywords

Pudendal neuralgia Chronic pelvic pain Pelvic floor physiotherapy Shear-wave elastography Pelvic floor muscle stiffness

Brief summary

This randomized controlled trial compares a 6-month physiotherapy exercise program versus no structured exercise intervention in women with pudendal neuralgia. Outcomes include pelvic floor muscle stiffness measured by shear-wave elastography (SWE), pelvic floor symptom burden (PFIQ-7), sexual distress (FSDS-R), and pain/discomfort scores (VAS).

Interventions

BEHAVIORALPelvic Floor Relaxation Protocol

A structured 6-month physiotherapy program was implemented, focusing on pelvic floor muscle relaxation, postural correction, and functional movement patterns.The program included 6 individual sessions with a physiotherapist and mandatory daily home exercise (30 minutes/day). Adherence was recorded in participant diaries.

Sponsors

Comenius University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Female participants aged 18 years or older * Confirmed diagnosis of pudendal neuralgia based on all five Nantes diagnostic criteria * Duration of symptoms at least 3 months * Written informed consent provided

Exclusion criteria

* History of psychiatric, neurological (except pudendal neuralgia), severe internal medical, orthopedic, or oncological disease * Botulinum toxin therapy within the previous 12 months * Pelvic surgery within the previous 12 months * Incomplete or incorrectly completed questionnaires * Refusal to participate or withdrawal of informed consent

Design outcomes

Primary

MeasureTime frameDescription
Pelvic floor muscle stiffness by shear-wave elastography (SWE)Baseline and 6 months (post-intervention)Pelvic floor muscle stiffness (kPa) measured by shear-wave elastography in superficial pelvic floor muscles (bulbospongiosus, ischiocavernosus, and superficial transverse perineal muscles). Measurements were obtained using a 2 mm circular ROI with real-time quality control (RLB \> 90%, M-STB 4-5 stars). Shell analysis was used to identify sites of minimum and maximum stiffness within each muscle.

Secondary

MeasureTime frameDescription
Pelvic Floor Impact Questionnaire-Short Form 7 (PFIQ-7)Baseline and 6 months (post-intervention)PFIQ-7 is a 21-item questionnaire assessing the impact of pelvic floor disorders across urinary, colorectal-anal, and prolapse/vaginal symptom domains. Total score ranges from 0 to 300; higher scores indicate greater negative impact on quality of life.
Female Sexual Distress Scale-Revised (FSDS-R)Baseline and 6 months (post-intervention)FSDS-R is a 13-item questionnaire measuring sexually related personal distress. Each item is scored on a 5-point Likert scale (0-4). Total score ranges from 0 to 52; higher scores indicate greater sexual distress.
Pain/discomfort intensity by visual analog scale (VAS)Baseline and 6 months (post-intervention)Pain and discomfort were assessed using VAS in five domains: bladder, vagina, perineum, rectum, and dyspareunia (pain during sexual intercourse).

Countries

Slovakia

Contacts

PRINCIPAL_INVESTIGATORMagdalena Hagovska, prof.PhDr.PhD.

Pavol Jozef Safarik University, Medical Faculty, Kosice Slovakia

STUDY_DIRECTORJan Svihra, prof.MUDr.PhD.

Comenius University Bratislava, Jessenius Faculty of Medicine in Martin, Slovakia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 9, 2026